Strategic Risk LLC. 13D and 13G filings for NeuroBo Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-28 3:30 pm Purchase | 2023-03-21 | 13G | NeuroBo Pharmaceuticals, Inc. NRBO | Strategic Risk LLC. | 150,354 6.300% | 150,354 (New Position) | Filing |
| 2023-03-27 4:36 pm Purchase | 2023-03-21 | 13G | NeuroBo Pharmaceuticals, Inc. NRBO | Strategic Risk LLC. | 150,354 6.300% | 150,354 (New Position) | Filing |